Clinical Trials in Houston

Showing 8901-8920 of 13,620 trials

ST266 Versus Standard Care In Treating Partial Thickness Burns

NCT00886470

The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal saline) solution in the same three treatment regimens.

Burns

Noveome Biotherapeutics, formerly Stemnion16 participantsStarted Jun 2009

Mobile, Alabama, United States • Los Angeles, California, United States • Gainesville, Florida, United States +11 more locations

COMPLETEDPhase 3< 1 mile

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

NCT01539512

This Phase 3, randomized, double-blind, placebo-controlled study is to evaluate the effect of idelalisib in combination with rituximab on the onset, magnitude, and duration of tumor control in participants previously treated for chronic lymphocytic leukemia (CLL). Eligible patients will be randomized with a 1:1 ratio into 1 of the 2 treatment arms to receive either idelalisib plus rituximab or placebo plus rituximab. Participants who are tolerating primary study therapy but experience definitive CLL progression are eligible to receive active idelalisib therapy in the extension study, GS-US-312-0117.

Chronic Lymphocytic Leukemia

Gilead Sciences220 participantsStarted Apr 2012

Huntsville, Alabama, United States • Tucson, Arizona, United States • La Jolla, California, United States +69 more locations

ST266 Versus Standard Care In Treating Partial Thickness Burns

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Find Trials by Condition in Houston

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

The Collection and Storage of Umbilical Cord Blood for Transplantation

A Study for Patients With Acute Leukemia

Prospective Study of Colonoscopic Resection of Large Polyps and Flat Lesions

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients

Genetic Study of Chronic Lymphocytic Leukemia Families

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Fenzian Asthma Multicenter Outcomes Study